The immunohistochemical analysis of membrane-bound CD55, CD59 and fluid-phase FH and FH-like complement inhibitors in cancers of ovary and corpus uteri origin

One of the potential therapeutic methods of cancer treatment is the immunotherapy with monoclonal antibodies. This kind of therapy, although devoid of serious side effects, has often insufficient efficacy. The presence of complement inhibitors on the cancer cells, which are able to inactivate comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapka-Skrzypczak, Lucyna, Wolinska, Ewa, Szparecki, Grzegorz, Czajka, Magdalena, Skrzypczak, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655386/
https://www.ncbi.nlm.nih.gov/pubmed/26648780
http://dx.doi.org/10.5114/ceji.2015.54598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655386/
https://www.ncbi.nlm.nih.gov/pubmed/26648780
http://dx.doi.org/10.5114/ceji.2015.54598

Ejemplares similares